Regional Monitoring EECA
by ECUO PLWH
Showing 1-13 of 13 items.
Excel
#CountrySource of financingManufacturerTradenameINNFormPrice per unit ($)Units in purchaseUnits in packagePrice per package ($)Packages in purchasePrice per purchase ($)DistributorYearPurchase dateDelivery dateRegisteredIn the list of main (vital) medicationsWHO prequalification
1Republic of PolandGovernmentGlaxoSmithKlineRetrovirZidovudine (AZT or ZDV)250mg caps11.246150556.23301686.9Krajowe Centrum ds. AIDS2016YesYesYes
2Russian FederationGovernmentBristol-Myers SquibbVidexDidanosine250mg caps0.97934503029.1311590646.52016Not specifiedYesNot specified
3Russian FederationGovernmentAurobindo Pharma Ltd.DidanosineDidanosine250mg caps1.1285157603033.8417192581777.252015Not specifiedNot specifiedNot specified
4Republic of ArmeniaGlobal FundAurobindo Pharma Ltd.Didanosine250mg caps0.4480301216192VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
5Russian FederationGovernmentBristol-Myers SquibbVidexDidanosine250mg caps1.12874755003033.86158505366812015Not specifiedNot specifiedNot specified
6Republiс of AzerbaijanGovernmentAurobindo Pharma Ltd.DidanosineDidanosine250mg caps0.9503174903028.5158316621.332015YesYesNot specified
7Republic of PolandGovernmentViiV HealthcareRetrovirZidovudine (AZT or ZDV)250mg caps2.375320040958076002015Not specifiedNot specifiedNot specified
8Republic of LatviaGovernmentViiV HealthcareRetrovirZidovudine (AZT or ZDV)250mg caps2.71354040108.541108.542015Not specifiedNot specifiedNot specified
9Republic of PolandGovernmentViiV HealthcareRetrovirZidovudine (AZT or ZDV)250mg caps2.375220004095550522502015Not specifiedNot specifiedNot specified
10Republic of PolandGovernmentGlaxoSmithKlineRetrovirZidovudine (AZT or ZDV)250mg caps0.86383600010086.3836031096.8Krajowe Centrum ds. AIDS2016YesYesYes
11Russian FederationGovernmentBoehringer IngelheimAptivusTipranavir250mg caps7.0161920120841.2516434059.192016YesYesNot specified
12Russian FederationGovernmentBoehringer IngelheimAptivusTipranavir250mg caps6.330836000120759.73002279102015Not specifiedNot specifiedNot specified
13Republic of LatviaGovernmentBoehringer IngelheimAptivusTipranavir250mg caps6.1753120120741.031741.032015Not specifiedNot specifiedNot specified